MetLife Investment Advisors LLC Sells 20,249 Shares of HMS Holdings Corp (HMSY)

MetLife Investment Advisors LLC reduced its position in HMS Holdings Corp (NASDAQ:HMSY) by 35.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 37,216 shares of the business services provider’s stock after selling 20,249 shares during the quarter. MetLife Investment Advisors LLC’s holdings in HMS were worth $1,047,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the stock. Oregon Public Employees Retirement Fund purchased a new position in HMS during the fourth quarter valued at approximately $32,000. We Are One Seven LLC purchased a new position in HMS during the fourth quarter valued at approximately $84,000. LS Investment Advisors LLC increased its holdings in HMS by 80.0% during the fourth quarter. LS Investment Advisors LLC now owns 5,016 shares of the business services provider’s stock valued at $141,000 after buying an additional 2,230 shares during the period. BlueMountain Capital Management LLC purchased a new position in HMS during the third quarter valued at approximately $146,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in HMS by 11.3% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,826 shares of the business services provider’s stock valued at $164,000 after buying an additional 592 shares during the period. 93.48% of the stock is currently owned by institutional investors.

In other HMS news, Director Bart M. Schwartz sold 20,000 shares of HMS stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $32.41, for a total value of $648,200.00. Following the completion of the transaction, the director now owns 74,874 shares of the company’s stock, valued at $2,426,666.34. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Meredith W. Bjorck sold 2,362 shares of HMS stock in a transaction on Monday, April 15th. The shares were sold at an average price of $30.10, for a total transaction of $71,096.20. Following the completion of the transaction, the insider now directly owns 51,755 shares of the company’s stock, valued at approximately $1,557,825.50. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,018,795 shares of company stock valued at $35,023,853. 2.87% of the stock is currently owned by corporate insiders.

NASDAQ:HMSY opened at $30.51 on Friday. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.40 and a quick ratio of 4.40. HMS Holdings Corp has a 12 month low of $17.11 and a 12 month high of $38.15. The firm has a market cap of $2.52 billion, a PE ratio of 36.32, a P/E/G ratio of 2.71 and a beta of 1.61.

HMS (NASDAQ:HMSY) last issued its earnings results on Friday, February 22nd. The business services provider reported $0.28 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.25 by $0.03. HMS had a net margin of 9.19% and a return on equity of 14.21%. The firm had revenue of $155.80 million during the quarter, compared to analysts’ expectations of $155.84 million. During the same quarter last year, the company posted $0.24 earnings per share. The firm’s revenue was up 4.9% compared to the same quarter last year. On average, equities analysts predict that HMS Holdings Corp will post 0.97 EPS for the current year.

HMSY has been the subject of several recent analyst reports. Zacks Investment Research upgraded shares of HMS from a “hold” rating to a “buy” rating and set a $32.00 target price for the company in a research note on Wednesday, January 16th. BidaskClub upgraded shares of HMS from a “hold” rating to a “buy” rating in a research note on Thursday, February 7th. Guggenheim initiated coverage on shares of HMS in a research note on Wednesday, April 17th. They issued a “buy” rating for the company. Finally, Cantor Fitzgerald restated a “hold” rating and issued a $34.00 target price on shares of HMS in a research note on Friday, February 22nd. One research analyst has rated the stock with a sell rating, three have given a hold rating and ten have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $33.04.

TRADEMARK VIOLATION WARNING: This piece was posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://www.baseballdailydigest.com/news/2019/04/27/hms-holdings-corp-hmsy-shares-sold-by-metlife-investment-advisors-llc.html.

About HMS

HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. The company offers coordination of benefits services to government and commercial healthcare payers to ensure that the correct party pays the claim; and population management solutions that provide risk-bearing organizations with intelligence across their member populations to identify risks, and enhance patient engagement and outcomes, as well as payment integrity, care management and consumer engagement, and analytical solutions.

Recommended Story: How a Strangle Strategy is different from a Straddle Strategy

Institutional Ownership by Quarter for HMS (NASDAQ:HMSY)

Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.